Amneal Enters U.S. Biosimilars Market With Approval of RELEUKO (filgrastim-ayow)
Amneal Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) approval of the Biologics License ...
Read moreAmneal Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) approval of the Biologics License ...
Read moreLupin Limited announced that the U.S. FDA has accepted the Biologics License Application (BLA) for its ...
Read more- Priority Review Granted with Action Date of August 17 - - Australia and Canada Regulators ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.